v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount
The following table summarizes our share-based compensation expense, which consists of the RSU expense, by line item in our condensed consolidated statements of income (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Cost of revenue$183 $209 $536 $582 
Research and development2,881 2,447 8,635 6,995 
Marketing and sales219 260 727 766 
General and administrative209 218 705 641 
Total share-based compensation expense$3,492 $3,134 $10,603 $8,984 
Restricted Stock Units Award Activity
The following table summarizes the activities for our unvested RSUs for the nine months ended September 30, 2023:
Number of SharesWeighted-Average Grant Date Fair Value Per Share
(in thousands)
Unvested at December 31, 2022127,110 $216.93 
Granted108,735 $198.34 
Vested(49,079)$210.58 
Forfeited(22,063)$210.81 
Unvested at September 30, 2023164,703 $207.37